TY - JOUR
T1 - EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
AU - Kidon, Mona
AU - Blanca-Lopez, Natalia
AU - Gomes, Eva
AU - Terreehorst, Ingrid
AU - Tanno, Luciana
AU - Ponvert, Claude
AU - Chin, Chiang Wen
AU - Caubet, Jean Christoph
AU - Soyer, Ozge
AU - Mori, Francesca
AU - Blanca, Miguel
AU - Atanaskovic-Markovic, Marina
PY - 2018
Y1 - 2018
N2 - Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatric population as antipyretics/analgesics and anti-inflammatory medications. Hypersensitivity (HS) reactions to NSAID in this age group, while similar to adults, have unique diagnostic and management issues. Although slowly accumulating, published data in this age group are still relatively rare and lacking a unifying consensus. This work is a summary of current knowledge and consensus recommendations utilizing both published data and expert opinion from the European Network of Drug Allergy (ENDA) and the Drug Hypersensitivity interest group in the European Academy of Allergy and Clinical Immunology (EAACI). This position paper summarizes diagnostic and management guidelines for children and adolescents with NSAIDs hypersensitivity.
AB - Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatric population as antipyretics/analgesics and anti-inflammatory medications. Hypersensitivity (HS) reactions to NSAID in this age group, while similar to adults, have unique diagnostic and management issues. Although slowly accumulating, published data in this age group are still relatively rare and lacking a unifying consensus. This work is a summary of current knowledge and consensus recommendations utilizing both published data and expert opinion from the European Network of Drug Allergy (ENDA) and the Drug Hypersensitivity interest group in the European Academy of Allergy and Clinical Immunology (EAACI). This position paper summarizes diagnostic and management guidelines for children and adolescents with NSAIDs hypersensitivity.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050808813&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/29693290
U2 - https://doi.org/10.1111/pai.12915
DO - https://doi.org/10.1111/pai.12915
M3 - Article
C2 - 29693290
SN - 0905-6157
VL - 29
SP - 469
EP - 480
JO - Pediatric allergy and immunology
JF - Pediatric allergy and immunology
IS - 5
ER -